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Endophytic actinomycetes from medicinal plants produce a wide diversity of secondary
metabolites (SM). However, to date, the knowledge about endophytes from Brazil
remains scarce. Thus, we analyzed the antimicrobial potential of 10 actinomycetes
isolated from the medicinal plant Vochysia divergens located in the Pantanal
sul-mato-grossense, an unexploredwetland in Brazil. Strains were classified as belonging
to the Aeromicrobium, Actinomadura, Microbacterium, Microbispora, Micrococcus,
Sphaerisporangium, Streptomyces, and Williamsia genera, through morphological and
16S rRNA phylogenetic analyzes. A susceptibility analysis demonstrated that the strains
were largely resistant to the antibiotics oxacillin and nalidixic acid. Additionally, different
culture media (SG and R5A), and temperatures (28 and 36◦C) were evaluated to
select the best culture conditions to produce the active SM. All conditions were
analyzed for active metabolites, and the best antibacterial activity was observed from
metabolites produced with SG medium at 36◦C. The LGMB491 (close related to
Aeromicrobium ponti) extract showed the highest activity against methicillin-resistant
Staphylococcus aureus (MRSA), with a MIC of 0.04 mg/mL, and it was selected for SM
identification. Strain LGMB491 produced 1-acetyl-β-carboline (1), indole-3-carbaldehyde
(2), 3-(hydroxyacetyl)-indole (4), brevianamide F (5), and cyclo-(L-Pro-L-Phe) (6) as major
compounds with antibacterial activity. In this study, we add to the knowledge about the
endophytic community from the medicinal plant V. divergens and report the isolation of
rare actinomycetes that produce highly active metabolites.
Keywords: actinomycetes, endophytes, Vochysia divergens, pantanal, MRSA, secondary metabolites
INTRODUCTION
Endophytes are microorganisms that inhabit the internal tissues of plants without causing any
negative effects, and actinomycetes isolated from plants have been widely studied due their ability
to produce active metabolites (Kim et al., 2000; Zhao et al., 2011; Kadiri et al., 2014; Golinska
et al., 2015; Savi et al., 2015a,b). Actinomycetes have been used for drug discovery for more than
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five decades, producing more than 10,000 bioactive compounds.
Of these ∼75% are produced by Streptomyces, the by far
mostly explored actinomycete genus. The remaining 25%
bioactive compounds were isolated from “rare actinomycetes”,
i.e., actinomycetes isolated in lower frequency than Streptomyces
(Rong and Huang, 2012; Tiwari and Gupta, 2012). Since,
the rare actinomycetes are an underexplored group, the use
of these organisms, and their compounds have gained great
importance in drug discovery programs (Rong and Huang, 2012;
Tiwari and Gupta, 2012), mainly to combat infections caused
by resistant microorganisms. The widespread use of broad-
spectrum antibiotics has created a strong selective pressure,
resulting in survival, and spread of resistant bacteria (Davies
and Davies, 2010). The increase in bacterial resistance is a major
concern for public health (Ventola, 2015). Unfortunately, many
pharmaceutical companies have reduced or eliminated their
search for new antibiotics, due to economic reasons, exasperating
the problem further (Borrero et al., 2014). In order to find
microorganisms with potential to produce active metabolites
our group has been searching endophytic microorganisms from
medicinal plants located in underexplored environments, such
as the Brazilian wetland regions (Savi et al., 2015a,b; Hokama
et al., 2016; Peña et al., 2016; Santos et al., 2016; Tonial et al.,
2017). The Brazilian Pantanal is the largest wetland in the world,
and it is characterized by two seasons: flooding and the dry.
Hence, the Pantanal has developed a peculiar biological diversity
regarding its fauna and flora (Alho, 2008). According to Arieira
and Cunha (2006), only 5% of the species of plants of the
Pantanal can survive the stress caused by drought and flood
periods. Among them is the medicinal plant Vochysia divergens,
which is commonly used in form of syrups and teas for the
treatment of colds, coughs, fever, pneumonia, and other diseases
(Pott et al., 2004). In a study carried out with endophytes from
V. divergens, Savi et al. (2015a) identified actinomycetes able
to produce highly active metabolites. However, the study was
performed with a small number of isolates, and the diversity
of V. divergens remained little explored. Thus, the focus of
this study is to identify endophytic actinomycetes from the
medicinal plant V. divergens and to assay their secondary
metabolites, dependent on different culture conditions, against
clinical pathogens associated with antibiotic resistance.
MATERIALS AND METHODS
Sample Collection
V. divergens leaves with no marks or injuries were collected
from 21 plants located in the Pantanal sul-mato-grossense/Brazil,
specifically in two regions of the Pantanal of Miranda, Abobral
(19◦30′09.5′′S, 57◦02′32.2′′W) and São Bento (19◦28′53.9′′S,
57◦02′36.9′′W).
Isolation of Actinomycetes
The leaves from V. divergens were subjected to surface
sterilization according to a protocol described by Petrini (1986).
The leaves were fragmented (8 × 8 mm) and deposited on petri
dishes containing starch casein agar (SCA) (Mohseni et al., 2013),
with nalidixic acid (50µg/mL) and cycloheximide (50µg/mL).
The plates were incubated at 28◦C for 30 days, and were
examined daily for the presence of colonies. The actinomycetes
isolates were deposited in the Laboratório de Genética de
Microrganismos (LabGeM) culture collection, Federal University
of Paraná, Brazil (http://www.labgem.ufpr.br/).
Identification
Morphological Analysis
Four different culture media were used to access the macro-
morphological characteristics, ISP2—Agar yeast-malt extract;
ISP3—Oat Agar; ISP4—Agar Starch and inorganic salts; ISP5—
Glycerol Asparagine Agar (Shirling and Gottlieb, 1966). The
isolates were streaked on the plates and incubated at 28◦C for
21 days. The characteristics evaluated were growth rate, the
formation and color of aerial spore mass and substrate mycelia.
Molecular Taxonomy
Total genomic DNA was extracted from 3 day old cultures
using the method described by Raeder and Broda (1985).
Partial sequence of the 16S rRNA gene was amplified using
primers 9F (5′GAGTTTGATCCTGGCTCAG3′) and 1541R
(5′AAGGAGGTGATCCAGCC3′), as described by Savi et al.
(2016). The PCR product was purified using Exo1 and FastAP
enzymes (GE Healthcare, USA), and sequenced using the
BigDye R© Terminator v3.1 Kit. The products were purified
with SephadexG50 and submitted to an ABI3500 R© automated
sequencer (Applied Biosystems, Foster City, CA, USA).
Consensus sequences were analyzed and aligned using Mega 6.0
(Tamura et al., 2013) and BioEdit, and compared to sequences
available in the GenBank database (http://www.ncbi.nlm.nih.
gov/BLAST/). Type strain sequences were found through search
in the List of Prokaryotic Names with Standing Nomenclature
database (http://www.bacterio.net/). All sequences obtained were
deposited in the GenBank, the accession numbers are listed in
Table 1. For Bayesian inference analysis, a Markov Chain Monte
Carlo (MCMC) algorithm was used to generate phylogenetic
trees with posterior probabilities using MrBayesv3.2.6 x86
(Ronquist et al., 2011). GRT evolutionary model was determined
using the Akaike Information Criterion (AIC) in R software (R
Core Team, 2017) and the phangorn package (Schliep, 2011).
Comparisons of sequences with respect to their percentile
similarity were estimated using the R software (R Core Team,
2017) and the pegas package (Paradis, 2010).
Antibiotic Sensitivity
The susceptibility of the endophytes to 11 antibiotics, oxacilin (a
penicillin), vancomycin (a glycopeptide), chloramphenicol (an
amphionicol), meropenem (a carbapenem), streptomycin (an
aminoglycoside), tetracycline (a tetracycline), gentamicin
(another aminoglycoside), rifampicin (a macrolactam),
ampicillin (another penicillins), ceftazidime (a third generation
cephalosporin), and nalidixic acid (a quinolone) were evaluated
as described by Passari et al. (2015). The analysis was performed
considering the isolate sensitive (S) with an inhibition zone
> 20mm, intermediate (I) with an inhibition zone of 10–19.9
mm and resistant (R), if the inhibition zone was between 0.0–9.9
mm (Williams et al., 1989).
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Biological Activity
Screening of Culture Conditions
Isolates were inoculated in 50 mL of SG medium (Shaaban et al.,
2011), incubated for 3 days at 36◦C and 180 rpm. Subsequently, 1
mL from the pre-culture was inoculated in SG and R5A media
(100 mL) (Fernandez et al., 1998), and incubated for 10 days
at two different temperatures, 28 and 36◦C, and 180 rpm. The
culture was filtered-off on Whatmann 4 filters, the water fraction
was extracted with EtOAc (3× 100 mL). The combined organics
were evaporated in vacuo at 40◦C and diluted in methanol at 10
mg/mL.
Antibacterial Activity–Disk Diffusion Assays
The antibacterial activity of crude extracts and the isolated
compounds 1–9 was evaluated against methicillin-sensitive
Staphylococcus aureus (MSSA) (ATCC 25923), methicillin-
resistant S. aureus (MRSA) (BACHC-MRSA), Pseudomonas
aeruginosa (ATCC 27853), Candida albicans (ATCC
10231), Acinetobacter baumannii (BACHC-ABA), Klebsiella
pneumoniae, the producer of the enzyme KPC (K. pneumoniae
carbapenemase) (BACHC-KPC), Stenotrophomonas maltophilia
(BACHC-SMA), and Enterobacter cloacae a producer of the
enzyme VIM (Verona integron-encoded metallo-β-lactamase)
(BACHC-VIM). The bacteria were cultivated for 12 h at 37◦C,
and diluted according to the McFarland standard 0.5 scale. Each
test organism was streaked on a sterile Mueller-Hinton agar plate
with a cotton swab. Extracts were aliquoted in 100µg amounts
per 6 mm sterile filter disc. The discs were placed on plates and
incubated for 24 h at 37◦C. The diameter halos were measured
in millimeters. As a positive control, a disc with a standard
antibiotic with activity against each of the bacteria was used, and
pure methanol was used as negative control (CLSI, 2015; Savi
et al., 2015b).
MIC–Minimum Inhibitory Concentration and
MBC–Minimum Bactericidal Concentration
Extracts from strain LGMB491 that showed high antibacterial
activity were selected to determine the minimum inhibitory
concentration. TheMIC of extracts against the clinical pathogens
was performed as described by Ostrosky et al. (2008) and CLSI.
The minimum bactericidal concentration was determined as
described by Soltani and Moghaddam (2014).
Statistical Analyses
The statistical analysis was performed using analysis of variance
(ANOVA) to compare extract effects to their respective controls.
We also performed Post-hoc tests using Tukey’s honest significant
difference. All tests premises were fulfilled; the significance level
used was 0.05 (α).
Large-Scale Fermentation, Extraction and Isolation
A large-scale fermentation (10 L) of strain LGMB491 was
performed using SG culture medium at 36◦C for 10 days. The
culture was subjected to extraction with EtOAc (3 × v/v), and
the combined organic layers were evaporated in vacuo at 40◦C to
yield 653mg of crude extract. The crude extract was subjected to
reverse phase C18 column chromatography (20 × 8 cm, 250 g),
eluted with a gradient of H2O-MeOH (100:0–0:100) to produce
fractions FI-FV. The single fractions were subjected to HPLC
and Sephadex LH-20 (MeOH; 1 × 20 cm) purifications to yield
compounds 1–9 in pure form (Figure 9, Figure S9). NMR spectra
were measured using a Varian (Palo Alto, CA) Vnmr 400 (1H,
400 MHz; 13C, 100 MHz) spectrometer, δ-values were referenced
to the respective solvent signals (CD3OD, δH 3.31 ppm, δC
49.15 ppm; DMSO-d6, δH 2.50 ppm, δC 39.51 ppm). HPLC-
MS analyses were accomplished using a Waters (Milford, MA)
2695 LC module (Waters Symmetry Anal C18, 4.6 × 250 mm,
5µm; solvent A: H2O/0.1% formic acid, solvent B: CH3CN/0.1%
formic acid; flow rate: 0.5 mL min−1; 0–4 min, 10% B; 4–22 min,
10–100% B; 22–27 min, 100% B; 27–29 min, 100–10% B; 29–30
min, 10% B). HPLC analyses were performed on an Agilent 1260
system equipped with a photodiode array detector (PDA) and a
Phenomenex C18 column (4.6 × 250 mm, 5µm; Phenomenex,
Torrance, CA). Semi-preparative HPLC was accomplished using
Phenomenex (Torrance, CA) C18 column (10 × 250 mm, 5µm)
on a Varian (Palo Alto, CA) ProStar Model 210 equipped with a
photodiode array detector and a gradient elution profile (solvent
A: H2O, solvent B: CH3CN; flow rate: 5.0 mL min
−1; 0–2 min,
25% B; 2–15 min, 25–100% B; 15–17 min, 100% B; 17–18 min,
100–25% B; 18–19 min, 25% B). All solvents used were of ACS
grade and purchased from the Pharmco-AAPER (Brookfield,
CT). Size exclusion chromatography was performed on Sephadex
LH-20 (25–100µm; GE Healthcare, Piscataway, NJ).
RESULTS
Isolation of Endophytic Actinomycetes
From 2,988 fragments analyzed, 10 endophytic actinomycetes
were isolated (Table 1), thus the isolation frequency was 0.34%.
From the 10 isolates, 70% (n= 7) were isolated from the Abobral,
and 30% (n = 3) from the São Bento region. Five isolates were
obtained from stems, and five from leaf tissues of the plant
(Table 1).
Morphological Identification
A great macro-morphological diversity was observed, with white,
ivory-white, pink, brown, gray, orange, and yellow colony colors.
Most of isolates showed abundant to moderate growth after 21
days of incubation, and six isolates showed abundant tomoderate
spore formation on ISP2 and ISP3 media. Isolates LGMB461 and
LGMB465 showed high morphological similarity, and probably
represent the same species (Table 1).
Molecular Analysis
Using a BLAST analysis in the GenBank database, the isolates
were classified as eight genera: Aeromicrobium, Williamsia,
Microbacterium, Sphaerisporangium, Micrococcus, Microbispora,
Actinomadura, and Streptomyces. Each genus was analyzed in a
separate phylogenetic tree based on Bayesian inference.
Actinomadura (LGMB466 and LGMB487)
The alignment consisted of strains LGMB466 and LGMB487,
55 type strains representative of Actinomadura genus, and
Streptomyces glauciniger (AB249964) as out group taxa. The
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analysis comprises of 1,402 characters, 1,011 of these were
conserved, 124 were parsimony informative and 131 were
uninformative. Strains LGMB466 and LGMB487 showed high
similarity among themselves (98.86%), and in the phylogenetic
analysis these isolates did not cluster with any species from the
Actinomadura genus (Figure 1, Table S1), and probably represent
a new species.
Aeromicrobium (LGMB491)
Strain LGMB491 was aligned with all type strains from the
Aeromicrobium genus (12 species), and Nocardioides albus
(X53211) was used as out group taxa. The alignment consisted
of 1,336 characters, 1,164 of these were conserved, 89 were
parsimony informative and 68 were uninformative. Based on
this phylogenetic analysis, strain LGMB491 is close related
to Aeromicrobium ponti (Figure 2), sharing high sequence
similarity, 99.25 % (Table S2).
Microbacterium (LGMB471)
Strain LGMB471 was aligned with type strains from the
Microbacterium genus, and Agrococcus jenensis (X92492) as out
group taxa. The alignment comprised of 1,314 characters, of
those 721 conserved sites, 122 were parsimony informative, and
57 uninformative. In the phylogenetic tree, isolate LGMB471
ended up in a single branch related to species Microbacterium
liquefaciens, Microbacterium maritypicum, Microbacterium
oxydans, Microbacterium luteolum, Microbacterium saperdae,
and Microbacterium paraoxydans (Figure 3, Table S3).
FIGURE 1 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB466, LGMB487, and the 53 type strain of Actionomadura genus. Values on the node
indicate Bayesian posterior probabilities. The species Streptomyces glauciniger was used as out group. Scale bar indicates the number of substitutions per site.
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FIGURE 2 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB491 and the 12 type strain of Aeromicrobium genus. Values on the node indicate Bayesian
posterior probabilities. The species Nocardioides albus was used as out group. Scale bar indicates the number of substitutions per site.
TABLE 2 | Antibiotic sensitivity pattern of endophytic actinomycetes.
Antibiotic sensitivity
Strain/Genera Oxa 1µg Van 30µg Clo 30µg Mer 10µg Est 10µg Tet 30µg Gen 10µg Rif 5µg Amp 10µg Caz 30µg Nal 30µg
Actinomadura sp.
LGMB466
R S I S S S S I R R R
Actinomadura sp.
LGMB487
S I R S S S S S I S S
Aeromicrobium ponti
LGMB491
R S R S S S S S R S S
Microbacterium sp.
LGMB471
R S I S S S S I R R R
Microbispora sp.
LGMB461
R S R R S S S I R R R
Microbispora sp.
LGMB465
R S R R S S I I R R R
Micrococcus sp.
LGMB485
R I R S I I I I R S R
Sphaerisporangium sp
LGMB482
R S I S S S S I R R R
Streptomyces
thermocarboxydus.
LGMB483
R S R S S I S R R R R
Williamsia serinedens.
LGMB479
R S R S S I S I I S R
Degree of susceptibility: >20 mm—Sensitive; 10–19.9 mm—intermediate; 0.0–9.9 mm resistant. Oxa, Oxacillin (1µg/disc); Van, Vancomycin (30µg/disc); Clo, Chloramphenicol
(30µg/disc); Mer, Meropenem (10µg/disc); Est, Streptomycin (30µg/disc); Tet, Tetracycline (30µg/disc);.Gen, Gentamicin (10µg/disc); Rif, Rifampicin (5µg/disc); Amp, Ampicillin
(10µg/disc); Caz, Ceftazidime (30µg/disc); Nal, Nalidixic acid (30µg/disc).
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FIGURE 3 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB471 and the 94 type strain of Microbacterium genus. Values on the node indicate Bayesian
posterior probabilities. The species Agrococcus jenensis was used as out group. Scale bar indicates the number of substitutions per site.
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Microbispora (LGMB461 and LGMB465)
The analysis comprises of strains LGMB461 and LGMB465,
10 species accepted in Microbispora genus, and the isolates
previously reported as Microbispora sp.1, Microbispora sp.2, and
Microbispora sp.3 (Savi et al., 2016). Actinomadura echinospora
(AJ420135) was used as out group taxa. The alignment
consists of 1,371 characters, 1,309 of these were conserved,
33 were parsimony informative, and 29 uninformative. In the
phylogenetic analysis strains LGMB461 and LGMB465 presented
similarity with Microbispora sp.1 (LGMB259) with 99.84 and
100% f similarity, respectively (Figure 4, Table S4).
Micrococcus (LGMB485)
The Bayesian analysis comprised of all Micrococcus type
strains, strain LGMB485 and Citricoccus parietis (FM9923367)
as out group taxa (Figure 5). The alignment consisted of
1,340 characters with 452 conserved sites, nine were parsimony
informative and 19 uninformative. Since the sequences were very
similar (Table S5) and the alignment had only nine parsimony
informative sites, a species designation cannot be assigned, and
isolate LGMB485 was identified asMicrococcus sp.
Sphaerisporangium (LGMB482)
For the Bayesian analysis, the sequence from LGMB482 was
aligned with strains of the Sphaerisporangium genus, and
Actinomadura madurae (X97889) was used as out group taxa.
The alignment consisted of 1,320 characters, 886 of these
were conserved, 51 were parsimony informative and 47 were
uninformative. Strain LGMB482 is closely related to S. melleum
AB208714 (99.4% similarity) and S. viridalbum X89953 (97.89%
similarity), however, it is in an isolated branch and may represent
a new species of the Sphaerisporangium genus (Figure 6,
Table S6).
Streptomyces (LGMB483)
The phylogenetic analysis was performed using 23 type strains
closely related with LGMB483; including Streptomyces albus
subsp. albus (X53163) as out group taxa. The alignment
consisted of 1,391 characters, with 1,291 conserved sites, 45
were parsimony informative, and 39 uninformative. In the
phylogenetic tree, isolate LGMB483 grouped with Streptomyces
thermocarboxydus, sharing 99.86% of similarity (Figure 7,
Table S7), and thus we suggest this isolate may belongs to this
species.
Williamsia (LGMB479)
The analysis consists of 11 sequences, including all type strains of
the Williamsia genus, the strain LGMB479, and Mycobacterium
tuberculosis (X58890) was used as out group taxa. The alignment
comprises of 1,346 characters, of these 1,185 were conserved, 81
were parsimony informative and 56 were uninformative. Strain
LGMB479 was in the same clade with Williamsia serinedens
(AM283464) (Figure 8) and share 99.85% sequence similarity
(Table S8), and may belongs to this species.
Antibiotic Sensitivity Test
In order to characterize the susceptibility profiles of the
endophytes, 11 antibiotics with different mechanisms-of-
action were utilized. Isolates were susceptible to vancomycin
(80% sensitive and 20% intermediate), streptomycin (90%
sensitive and 10% intermediate), tetracycline (70% sensitive
and 30% intermediate), and gentamicin (80% sensitive and 20%
intermediate). The two isolates of Microbispora sp. (LGMB461
and LGMB465) showed resistance to meropenem, and 90% of
the isolates showed resistance to oxacillin, and nalidixic acid
(Table 2).
Antibacterial Activity of Crude Extracts
All strains and culture conditions analyzed produced active
extracts (Table 3, Table S9), however, the extract from LGMB491
(close related to A. ponti) cultured in SG medium at 36◦C
showed great antibacterial activity against S. aureus (22 mm)
and MRSA (19.8 mm), and moderate activity against others
clinical pathogens (Table 3, Figures S1–S8). The MIC and MBC
of extract from LGMB491 against S. aureus and methicillin-
resistant S. aureus were 0.02, and 0.04 mg/mL, respectively,
and the MBC was 5 mg/mL for both bacteria (Table 4). In
addition, the crude extract from LGMB491 had an MIC of 0.63
mg/mL against gram-negative bacteria associated with antibiotic
resistance, K. pneumoniae KPC, S. maltophilia, and E. cloacae
VIM, and a MIC of 0.31 mg/mL against A. baumannii and
P. aeruginosa, respectively (Table 4).
Structure Determination of Secondary
Metabolites from Strain LGMB491
Scale-up fermentation of strain LGMB491 (10 L) using SG
medium, followed by extraction afforded 653mg of crude
extract. Fractionation, isolation and purification of the obtained
extract using various chromatographic techniques resulted
in compounds 1–9 in pure forms (Figure S9). Thorough
analyses of the HPLC/UV, ESIMS and NMR spectroscopy
data (Figure S10–S43), and by comparison with literature data
(Laatsch, 2012), the compounds were identified as 1-acetyl-β-
carboline (1) (Shaaban et al., 2007; Savi et al., 2015b), indole-
3-carbaldehyde (2) (Zendah et al., 2012; Savi et al., 2015b),
tryptophol (3) (Rayle and Purves, 1967), 3-(hydroxyacetyl)-
indole (4) (Zendah et al., 2012), brevianamide F (5) (Shaaban,
2009), cyclo-(L-Pro-L-Phe) (6) (Barrow and Sun, 1994), cyclo-
(L-Pro-L-Tyr) (7) (Barrow and Sun, 1994), cyclo-(L-Pro-L-
Leu) (8) (Yan et al., 2004), and cyclo-(L-Val-L-Phe) (9)
(Pickenhagen et al., 1975) (Figure 9). In order to determine
the compounds responsible for the biological activity observed
for the crude extract of strain LGMB491, we evaluated the
antibacterial activity of compounds 1–9 against S. aureus and
methicillin-resistant S. aureus. 1-Acetyl-β-carboline (1) showed
an equivalent activity as the antibiotic methicillin against
S. aureus, however, different from this antibiotic, compound
1 also showed activity against MRSA (Table 5). In addition,
compounds 2, 4–6 also showed moderate activity against both
MSSA and MRSA.
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FIGURE 4 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB461, LGMB465, the 10 type strain of Microbispora genus, and 7 strains previously reported
by Savi et al. (2016). Values on the node indicate Bayesian posterior probabilities. The species Citricoccus parietis was used as out group. Scale bar indicates the
number of substitutions per site.
FIGURE 5 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB485 and the 9 type strain of Micrococcus genus. Values on the node indicate Bayesian
posterior probabilities. The species Citricoccus parietis was used as out group. Scale bar indicates the number of substitutions per site.
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FIGURE 6 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB482 and the 10 type strain of Sphaerisporangium genus. Values on the node indicate
Bayesian posterior probabilities. The species Actinomadura madurae was used as out group. Scale bar indicates the number of substitutions per site.
FIGURE 7 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB483 and the 33 type strain of Streptomyces genus. Values on the node indicate Bayesian
posterior probabilities. The species Streptomyces albus subsp.albus was used as out group. Scale bar indicates the number of substitutions per site.
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FIGURE 8 | Bayesian phylogenic tree based on 16S rRNA gene of LGMB479 and the 9 type strain ofWillamsia genus. Values on the node indicate Bayesian posterior
probabilities. The species Mycobacterium tuberculosis was used as out group. Scale bar indicates the number of substitutions per site.
DISCUSSION
Endophytes Isolation and Identification
Actinomycetes from medicinal plants are the source of several
secondary metabolites with biological activity (Qin et al., 2015;
Savi et al., 2015b), and their metabolites may be associated
with the medicinal properties of the plant host (Kusari et al.,
2013; Santos et al., 2015). We explored the endophytes from
the medicinal plant V. divergens, in order to catalog the species
richness and biological properties. A low frequency of isolation
(0.34%), compared with the isolation of terrestrial actinomycetes,
was observed, in agreement with literature data (Passari et al.,
2015). However, despite the lower isolation frequency a higher
richness of genera was observed (Passari et al., 2015; Saini
et al., 2016). We reported for the first time the isolation of
strains close related to the species A. ponti (LGMB491) and
Williamsia serinedens (LGMB479) as endophytes. A. ponti
was originally isolated from seawater (Lee and Lee, 2008),
and has been found in this environment (Jiang et al., 2010;
Claverias et al., 2015). W. serinedens was first isolated from an
oil-contaminated soil sample and it is common isolated from
different types of soil (Yassin et al., 2007). In addition, species
S. thermocarboxydus was isolated from soil (Kim et al., 2000),
and was recently described as endophyte from a medicinal
plant in India (Passari et al., 2015). Based on the 16S rRNA
phylogenetic analysis we suggest that strains LGMB471 and
LGMB482 may represent new species within theMicrobacterium
and Sphaerisporangium genera, respectively (Figures 3, 6), and
isolates LGMB466 and LGMB487 seem to be a new species
within the Actinomadura genus (Figure 1). Isolates LGMB461
and LGMB465 belong to genus Microbispora, and showed high
sequence similarity with strains belonging to Microbispora
sp.1 group, previously isolated from V. divergens (Savi et al.,
2016). However, sequencing others genes than 16S rRNA,
and DNA-DNA hybridization would be required for species
description (Meyers, 2014).Microbacterium, Sphaerisporangium,
and Micrococcus species are common associated with medicinal
plants in different regions, and climate conditions (Kim et al.,
2000; Kamil et al., 2014; Xing et al., 2015). However, none
of these has been isolated from wetland regions. Savi et al.
(2015a) performed the first report about actinomycetes from
the medicinal plant V. divergens. However, despite the higher
number of isolates, the authors then just identified three genera
as endophytes from this plant, Microbispora, Micromonospora,
and Streptomyces. In addition to those genera previously
mentioned (Microbispora and Streptomyces) we isolated species
belonging to Actinomadura, Aeromicrobium, Microbacterium,
Sphaerisporangium, Micrococcus, and Williamsia (Figures 1–8),
thereby significantly increasing the knowledge regarding
endophytes from V. divergens.
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TABLE 4 | Minimum Inhibitory and Minimum Bactericidal Concentrations of the
extract from strain Aeromicrobium ponti LGMB491.
Microrganism MIC (mg/mL) MBC
Methicillin-sensitive S. aureus (MSSA) 0.02 5.0
Methicillin-resistant S. aureus (MRSA) 0.04 5.0
Acinetobacter baumannii 0.31 0. 63
Pseudomonas aeruginosa 0.31 0.63
Enterobacter cloacae producer of VIM 0.63 1.25
Klebsiella pneumoniae producer of KPC 0.63 1.25
Stenotrophomonas maltophilia 0.63 1.25
Antibiotic Sensitivity Assay
In order to characterize the susceptibility profile as well as to
suggest antibiotics to be used in actinomycete isolation, we
evaluated the susceptibility profile of endophytes. We detected
significant resistance to antibiotics oxacillin and nalidixic acid,
only strain Actinomadura LGMB487 was sensitive to both
compounds (Table 2). Nalidixic acid is the antibiotic used
to inhibit bacterial growth during actinomycete isolation,
however, even with the use of this compound, the presence
of contaminating bacteria was common (Baskaran et al.,
2011; Kadiri et al., 2014). Therefore, based on the high
resistance to oxacillin observed in this study, we suggest the
use of this antibiotic to inhibit bacterial growth during the
isolation of actinomycetes. Strains LGMB466 and LGMB487,
both characterized as Actinomadura sp., showed a complete
different sensitivity pattern: strain LGMB487 was resistant only
to chloramphenicol, and LGMB466 showed resistance to four
antibiotics, and intermediate resistant to chloramphenicol, and
rifampicin, suggesting that the resistance profile of isolates is not
associated with the intrinsic factors of Actinomadura genus. The
resistance observed in these strains can result from the presence
of plasmids, which contributes to the well-known problem of
antibiotic resistance (Wintersdorff et al., 2016). In addition,
vancomycin, streptomycin, tetracycline, and gentamicin were
previously reported from actinomycetes (Gonzalez and Spencer,
1998; Chopra and Roberts, 2001; Levine, 2006; Zumla et al.,
2013), however, all strains evaluated here showed some sensitivity
level to these antibiotics, which suggest that these compounds are
not present as secondary metabolites from our isolates.
Biological Activity and Secondary
Metabolites Identification
All isolates and conditions analyzed produced active secondary
metabolites, ratios superior than observed in previous studies
(Higginbotham and Murphy, 2010; Passari et al., 2015; Tonial
et al., 2016), suggesting the high biotechnological potential
of the evaluated strains. This may be related to the culture
conditions used to obtain the secondary metabolites. Extracts
from LGMB491 (close related to A. ponti) showed great activity
against MRSA, with inhibition zones higher than caused by
vancomycin, the clinical antibiotic used for the treatment of
this resistant bacterium (Table 3). In addition, extracts from
strain LGMB491 also had considerable MIC, and MBC values
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FIGURE 9 | Chemical structure of compounds isolated from strain Aeromicrobium ponti LGMB491.
TABLE 5 | Inhibition zone (mm) growth of methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) of compounds 1–9 (100µg/disk).
h
h
h
h
h
h
h
h
h
h
hh
Microorganism
Compounds
1 2 3 4 5 6 7 8 9 Methicillin
MSSA 18 10 10 10 11 10 – – – 20
MRSA 15 9 – 8 9 9 – – – –
against S. aureus, MRSA, K. pneumoniae KPC, S. maltophilia,
A. baumannii, P. aeruginosa, and E. cloacae VIM. These data
suggest the presence of metabolites with broad spectrum activity
(Smith et al., 2011). Compounds with broad spectrum activity are
required to treat multidrug resistant pathogens, such as MRSA,
S. maltophilia, P. aeruginosa, and A. baumannii (Bonomo and
Szabo, 2006; Çıkman et al., 2016), bacteria that are considered
one of the most urgent issues in modern healthcare (Paulus
et al., 2017). Therefore, due to the good activity observed,
and the absence of studies about metabolites with biological
activity from A. ponti species, we decided to characterize the
major compounds produced by strain LGMB491. From the nine
secondary metabolites isolated, 1-acetyl-β-carboline (1) turned
out to be the compound responsible for the antibacterial activity
of the LGMB491 extract. The compound displayed high activity
against the MRSA (Table 5). β-carbolines are normally isolated
from plants with a large spectrum of biological activity (Lee
et al., 2013). Savi et al. (2015b) reported the production of
four β-carbolines by the Microbispora sp. 1 also isolated from
V. divergens. The authors isolated as the major metabolite the
compound 1-vinyl-β-carboline-3-carboxylic acid, and attributed
the vinyl chain as the likely responsible structural feature causing
the antibacterial activity of this natural product. However, 1-
acetyl-β-carboline (1), found during this study, showed also
high biological activity, which is unlikely associated with the
acetyl chain in position 1. Several studies demonstrated great
activity of compound 1 against MRSA, and suggest the use
of this compound for an effective treatment of this resistant
bacterium (Shin et al., 2010; Lee et al., 2013). In addition to
1-acetyl-β-carboline (1), compounds 2–6 displayed moderate
antibacterial activity, and may act synergistically with compound
(1), contributing for the activity observed. Brevianamide F (5),
an alkaloid, was isolated for the first time from Penicillium
brevicompactum (Birsh and Wright, 1969), and has nematocidal
(Shiomi and Omura, 2004), anti-inflammatory (Rand et al.,
2005), and antibacterial activity against methicillin-sensitive and
resistant S. aureus (Kumar et al., 2014; Alshaibani et al., 2016).
Cyclo-(L-Pro-L-Phe) (6) is a diketopiperazine, i.e., a member of
these cyclic dipeptides commonly isolated from microorganisms
that have been associated with antimicrobial activity, and plant
growth regulation (Zhang et al., 2013; Kalinovskaya et al., 2017).
Interesting, several diketopiperazines, including cyclo-(L-Pro-L-
Phe), were previously isolated from Aspergillus fumigatus from a
soil sample of the Pantanal, and showed high antibacterial activity
against S. aureus (Furtado et al., 2005), which supports the idea
of synergism of the compounds produced by strain LGMB491.
The indoles isolated from strain LGMB491 are commonly
produced by plants and endophytic microorganism (Braga et al.,
2016). 3-(Hydroxyacetyl)-indole (4) showed a broad-spectrum
antibacterial activity against methicillin-resistant S. aureus, and
against vancomycin-sensitive or resistant Enterococci, attributed
to disruption of cell membrane (Sung and Lee, 2007). In plants,
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indole-3-carbaldehyde (3) is associated with the innate immunity
to microbial pathogen infections (Stahl et al., 2016). This
compound was also produced by Microbispora sp. 1 previously
isolated from the medicinal plant V. divergens (Savi et al.,
2015b). Some studies suggested that indole compounds play an
important role in plant-microorganism interaction and plant
defense (Gamir et al., 2012; Lin and Xu, 2013; Jeandet et al.,
2014).
CONCLUSION
In this study, we increased the knowledge regarding the
endophytic community of the medicinal plant V. divergens,
through the isolation of rare actinomycetes, some of which
were never described as endophytes. We identified for the first
time some secondary metabolites produced by one strain close
related to the species A. ponti, and demonstrated that this
species is able to produce indoles, β-carbolines, brevianamide,
and diketopiperazines. Future studies to evaluate the potential
of these compounds in animal models are required to better
understand the potential of compound 1-acetyl-β-carboline as
an alternative to treat MRSA infections. Our results indicate that
actinomycetes from V. divergens have biotechnological potential
as producer of bioactive compounds.
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